Obese patients have many physical limitations and much psychiatric burden to overcome.
Several studies have shown that the prevalence of psychiatric morbidity in the obese is
similar to those with normal weight. However, in obese patients seeking treatment there is an
increased prevalence (40-60%) of psychiatric morbidity, most commonly depression. It is
difficult to separate the effects of depression on obesity and, on the contrary, the neuroendocrine
changes associated with stress and depression may cause metabolic changes that predispose
and perpetuate obesity. The stigma associated with obesity causes bullying in school
as well as childhood psychiatric morbidity. Prejudice is not limited to the general public but
exists among health professionals too. This chapter discusses the treatment of depression in
obesity and the psychiatric evaluation of the pre-bariatric surgery patient. Education of society,
starting with schools and including healthcare professionals will reduce bias and stigma
as well as assist this vulnerable group of patients to seek help for their obesity and the many
problems that come with it. Given that by the year 2025 obesity will be the world’s number
one health problem with the US leading the way, it is very important that we pursue preventive
measures as well as encourage research for treatments of obesity.
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.